发明名称 Pharmaceutical composition comprising pyrazine derivative, and method of using pyrazine derivative in combination
摘要 Disclosed is a pharmaceutical composition comprising a pyrazine derivative represented by the general formula:; [wherein R1 and R2 independently represent a hydrogen atom or a halogen atom; and R3 represents a hydrogen atom or an amino-protecting group] or a salt thereof and at least one neuraminidase inhibitor. The pharmaceutical composition is useful for a treatment including the treatment or prevention of influenza. Also disclosed is a method of using these components in combination. The method is useful for a treatment including the treatment or prevention of influenza.
申请公布号 US8759354(B2) 申请公布日期 2014.06.24
申请号 US200812527260 申请日期 2008.02.14
申请人 Toyama Chemical Co., Ltd. 发明人 Maekawa Masako
分类号 A61K31/4965;A61K31/35;A61K31/22;A61K31/225 主分类号 A61K31/4965
代理机构 Oblon, Spivak, McClelland, Maier & Neustadt, L.L.P. 代理人 Oblon, Spivak, McClelland, Maier & Neustadt, L.L.P.
主权项 1. A pharmaceutical composition for treating influenza virus infection, comprising (A) a pyrazine derivative represented by the following general formula or a salt thereof; and (B) a neuraminidase inhibitor selected from the group consisting oseltamivir, zanamivir, peramivir, and CS-8958: wherein R1 is a hydrogen atom, R2 is fluorine, and R3 is a hydrogen atom, and wherein (A) and (B) are in synergistic and effective amounts.
地址 Tokyo JP